PHARMA DMS
ActiveSummary
PHARMA DMS has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €177,668 and a net result of €71,146. Equity remains stable across the filed financial years (±0.2% per year). Its solvency ranks better than 64% of 12,578 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
10-07
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
31-12
Financial
Highest result from 2018 to 2025net €71,146 ▲3.1%
Operating result €71,284, net result €71,146, both a record.
15-07
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
12-07
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
16-06
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
09-06
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
28-06
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2020
20-07
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format
2019
31-12
Financial
Back to profitnet €61,638
Net result €61,638 after one loss-making year.
04-07
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format
2018
17-08
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format · 17 days late
2017
28-08
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format · 28 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 16 annual accounts filed, the latest 10 are here; all 16 are under Financials.
0 of 3 deeds read
About the unread acts
We know of 3 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.